|Publication Type||Journal Article|
|Year of Publication||2005|
|Authors||Martin, S, Hohman, MM, Liefeld, T|
|Journal||Drug Discovery Today|
|Pages||1566 - 72|
|Keywords||Cancer, Computational Biology, Databases, Genetic, Information Storage and Retrieval, Software Design|
Since the Life Science Identifier (LSID) data identification and access standard made its official debut in late 2004, several organizations have begun to use LSIDs to simplify the methods used to uniquely name, reference and retrieve distributed data objects and concepts. In this review, the authors build on introductory work that describes the LSID standard by documenting how five early adopters have incorporated the standard into their technology infrastructure and by outlining several common misconceptions and difficulties related to LSID use, including the impact of the byte identity requirement for LSID-identified objects and the opacity recommendation for use of the LSID syntax. The review describes several shortcomings of the LSID standard, such as the lack of a specific metadata standard, along with solutions that could be addressed in future revisions of the specification.